from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0769/-

LFCtreatmentdescriptionclass of inhibitor

-0.392

Amikacinug/mL Amikacintranslation

0.012

Cap5-10ug/mL Capreomycintranslation

0.035

Rox10-50 ug/mL Roxithromycintranslation

1.630

SM2-5 ug/mL Streptomycintranslation

-1.884

Tet5-10 ug/mL Tetracyclinetranslation

0.128

Rif0.2-5ug/mL Rifampicintranscription

-0.260

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.345

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.320

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.066

CPZ10-50 ug/mL Chlorpromazinerespiration

0.270

Clofazimine10-13 ug/mL Clofaziminerespiration

0.514

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.559

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.401

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.222

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.311

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.221

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.086

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.985

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.866

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.246

KCN5-20 ug/mL Potassium cyaniderespiration

0.257

NaN30.2-2 mM Sodium aziderespiration

0.729

Nigericin50 uM Nigericinrespiration

-0.388

TRC10-150 ug/mL Triclosanrespiration

0.661

TRZ10-25 ug/mL Thioridazinerespiration

0.435

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.719

menadione6-10 ug/mL Menadionerespiration

1.089

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.296

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.956

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.245

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.706

NRP_1Non-replicating persistence stage 1dosRassociated

-0.413

Amp0.2mg/mL AmpicillincellWall

-0.018

Cephalexin20-100 ug/mL CephalexincellWall

0.200

Cerulenin0.32-5 ug/mL CerulenincellWall

0.248

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.328

EMB10-20 ug/mL EthambutolcellWall

0.174

Eta12-40 ug/mL EthionamidecellWall

-0.095

INH0.2-0.4 ug/mL IsoniazidcellWall

0.081

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.159

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.133

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.655

BZA0.12 mg/mL BenzamidearomaticAmides

-0.405

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.068

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.428

H2O24 mM hydrogen peroxideDNAdamaging

0.351

Levo10 ug/mL LevofloxacinDNAdamaging

-0.014

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.562

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.407

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.260

UVUV-irradiationDNAdamaging

1.980

ARP41-4 ug/mL Antitubercular compound ARP4?

0.318

Antimycin12.5-50 ug/mL Antimycin A?

-0.148

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.148

PA_110-50 ug/mL Antitubercular compound PA-1?

0.559

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.733

PA8240.2-2 ug/mL PA-824?

-0.666

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.107

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.126

Verapamil50 uM Verapamil?

0.097

mercaptoethanol2 mM 2-Mercaptoethanol?

0.153

methoxatin10-20 ug/mL Methoxatin?